BridgeBio Oncology Therapeutics, Inc (BBOT)

Last Closing Price: 1.80 (2026-11-18)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

BridgeBio Oncology Therapeutics, Inc (BBOT) had Earnings per Share (EPS) (Diluted) of $-0.43 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-34.18M
--
--
$37.49M
$-37.49M
$3.31M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-37.49M
$-37.30M
80.19M
80.19M
$-0.43
Earnings per Share (EPS) (Diluted)
$-0.43
Balance Sheet Financials
$208.33M
$0.81M
$137.90M
$346.22M
$51.03M
--
$1.81M
$52.84M
$293.39M
$293.39M
$293.39M
80.23M
Cash Flow Statement Financials
$-108.64M
$-189.34M
$0.77M
$373.82M
$76.61M
$-297.21M
$15.84M
--
--
Fundamental Metrics & Ratios
4.08
--
--
--
--
--
--
--
--
--
--
$-108.73M
--
--
--
--
--
--
--
-11.65%
-11.65%
-9.87%
-11.65%
$3.66
$-1.36
$-1.35